ArticleEnvironmental and molecular mutagenesis2025
Identifying Gene Predictors of Chemicals Linked With Breast Cancer: A Machine Learning Analysis of MCF7 Cellular Transcriptomic Screening Data.
Article in Environmental and molecular mutagenesis, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
1 citing paper in PubMed.
- Identifying Gene Predictors of Chemicals Linked With Breast Cancer: A Machine Learning Analysis of MCF7 Cellular Transcriptomic Screening Data.Environmental and molecular mutagenesis · 2025Article
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
3 authors.
Funding
Abstract
Breast cancer is the most prevalent cancer in women and has been linked to exposure to environmental chemicals. However, many chemicals have not been evaluated for relationships with this outcome. In this study, we analyzed RNA sequencing data from human breast cancer-derived MCF7 cells exposed to hundreds of individual chemicals. These chemicals were binned into three categories: (1) chemicals with known associations to breast cancer (BCs); (2) chemicals with a lack of relationship to breast cancer (NBCs); and (3) chemicals that remain understudied for breast cancer risk (UCs). Machine learning models were trained to discriminate between BCs and NBCs based on transcriptomic and physicochemical property data. The best model yielded a balanced accuracy of 80% and was applied to the UCs. A total of 170 genes were found to contribute to model performance, including Claspin (CLSPN), Runt-related Transcription Factor 2 (RUNX2), and Ubinuclein 2 (UBN2). These genes further informed enriched pathways relevant to inflammation, ferroptosis signaling, and cell proliferation. Additionally, 97 UCs were predicted to be more analogous to BCs, including select biocides and dyes. To ground results in human population data, expression profiles for the 170 genes were assessed in tumor samples from The Cancer Genome Atlas, yielding overlap in human cancer-relevant alterations and in vitro chemical-induced alterations. Collectively, this study addresses a gap related to understanding which chemicals may be of interest for further characterization of breast cancer risk by prioritizing chemicals and underlying mechanisms using high-throughput transcriptomic screening data.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.